Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$113.87 1.3  1.1%

Last Trade - 18/09/20

Sector
Healthcare
Size
Large Cap
Market Cap £11.84bn
Enterprise Value £14.72bn
Revenue £5.83bn
Position in Universe 562nd / 6396

BRIEF-Quest Diagnostics Says Now Able To Provide Up To 150,000 COVID-19 Molecular Diagnostic Tests A Day

Mon 10th August, 2020 11:17pm
Aug 10 (Reuters) - Quest Diagnostics Inc  DGX.N :
    * QUEST DIAGNOSTICS INC - HAS REPORTED RESULTS OF
APPROXIMATELY
11.2 MILLION COVID-19 MOLECULAR DIAGNOSTIC TESTS PERFORMED TO
DATE
    * QUEST DIAGNOSTICS - ARE NOW ABLE TO PROVIDE UP TO 150,000
COVID-19 MOLECULAR DIAGNOSTIC TESTS A DAY VERSUS 120,000 TESTS
AT THE BEGINNING OF JULY
    * QUEST DIAGNOSTICS - EXPECT TO SCALE UP CAPACITY TO PROVIDE
185,000 COVID-19 MOLECULAR DIAGNOSTIC TESTS A DAY BY LABOR DAY,
WITH FURTHER GAINS POSSIBLE
    * QUEST DIAGNOSTICS INC - AVERAGE TURNAROUND TIME FOR
COVID-19
MOLECULAR DIAGNOSTIC TESTING IS NOW DOWN TO 2-3 DAYS FOR
INCOMING SPECIMENS

Source text: (https://bit.ly/33Lp6v3)
Further company coverage:  DGX.N 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.